US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist
  • 145.280
  • -0.410-0.28%
Close Jul 22 16:00 ET
  • 145.280
  • 0.0000.00%
Post 16:20 ET
14.62BMarket Cap39.48P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurocrine Biosciences Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

547.82M

+21.01%
EPS(YoY)

1.03

+8.92%
Analyst Rating

Strong Buy

Jul 22, 2024

Neurocrine Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 569.451M--
Aug 1, 20242024/Q2-- / 547.822M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--
Oct 31, 20232023/Q3498.800M / 479.026M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 569.451M--
Aug 1, 20242024/Q2-- / 547.822M--
May 1, 20242024/Q1515.300M / 512.006M--
Feb 7, 20242023/Q4515.200M / 518.389M--
Oct 31, 20232023/Q3498.800M / 479.026M--

Unlock Free Earnings Estimates

Neurocrine Biosciences Earnings Reports

  • Neurocrine Biosciences | 10-Q: Quarterly report

    May 1 07:09 ET

  • Neurocrine Biosciences | 10-K: Annual report

    Feb 9 17:31 ET

  • Neurocrine Biosciences | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 07:02 ET

  • Neurocrine Biosciences | 10-Q: Q2 2023 Earnings Report

    Aug 1, 2023 07:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      78.95%

    • Hold

      21.05%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg